14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -5.875 45 days ( 70.44 % )
Last Price $0.0047 9.30 %
High/ Low $0.0040 - $0.0051 7.50%
Chg 7 Days -4.86 % $0.0049 $0.0047
Chg 30 Days -45.98 % $0.0087 $0.0047
Chg 12 mos -95.73 % $0.110 $0.0047
Trend - 3 mos -76.68 % Width: 1,283.98 %
Trend - 12 mos -93.55 % Width: 134.94 %
Pred. range - 3 mos $0.00007347 - $0.0010 -98.44 % - -78.37 %
Pred. range - 12 mos N/A - $0.0003 -100.00 % - -94.09 %
Short MA avg 3 mos Buy May 06, 2024 - 2 days
Long MA avg 3 mos Sell Mar 04, 2024 - 46 days
Short/Long MA avg 3 mos Sell Mar 08, 2024 - 42 days
Short MA avg 12 mos Sell Mar 06, 2024 - 44 days
Long MA avg 12 mos Sell May 24, 2023 - 240 days
Short/Long MA avg 12 mos Sell Jun 12, 2023 - 228 days
Pivot Short Sell May 01, 2024 - 5 days
Bollinger Buy Aug 02, 2023 - 193 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Enzolytics Inc

Enzolytics Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, it has created a proprietary cell l... ENZC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT